Curated Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,324
Closed -$205K 142
2023
Q2
$205K Buy
+2,324
New +$200K 0.04% 131
2022
Q3
Sell
-2,381
Closed -$215K 131
2022
Q2
$215K Sell
2,381
-1,747
-42% -$177K 0.06% 118
2022
Q1
$427K Hold
4,128
0.14% 85
2021
Q4
$427K Sell
4,128
-339
-8% -$39.3K 0.14% 88
2021
Q3
$560K Buy
4,467
+34
+0.8% +$4.4K 0.31% 64
2021
Q2
$550K Buy
4,433
+435
+11% +$54.6K 0.3% 65
2021
Q1
$472K Sell
3,998
-398
-9% -$46.6K 0.29% 70
2020
Q4
$515K Buy
+4,396
New +$484K 0.33% 57

Other funds holding MDT

Curated Wealth Partners's MDT Position: Q3 2023 in Review

Curated Wealth Partners sold out of Medtronic (MDT) in Q3 2023, closing a stake of 2,324 shares — an estimated $205K sold.

Curated Wealth Partners first reported a position in MDT in Q4 2020 and held it in 8 quarters. The position peaked at $560K in Q3 2021. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Curated Wealth Partners reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Curated Wealth Partners sold 2,324 Medtronic shares in Q3 2023, an estimated $205K.
  • Curated Wealth Partners first reported a position in Medtronic in Q4 2020 and held it in 8 quarters.
  • Curated Wealth Partners's Medtronic position peaked at $560K in Q3 2021.
  • 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Curated Wealth Partners's 13F filing for Q3 2023, filed 24 Oct 2023.